Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Scholar Rock Holding Corporation(SRRK) | 3,904,456 | 5,220,846 | +1,316,390 | $145.40M | $229.98M | 16.94% | +$84.58M |
| Krystal Biotech, Inc.(KRYS) | 661,388 | 677,705 | +16,317 | $116.75M | $167.08M | 12.30% | +$50.33M |
| Nurix Therapeutics, Inc.(NRIX) | 3,678,394 | 8,093,908 | +4,415,514 | $33.99M | $153.54M | 11.31% | +$119.55M |
| Stoke Therapeutics, Inc.(STOK) | 4,175,542 | 4,034,070 | -141,472 | $98.13M | $128.04M | 9.43% | +$29.92M |
| Immunome, Inc.(IMNM) | 5,023,385 | 5,718,385 | +695,000 | $58.82M | $122.83M | 9.05% | +$64.01M |
| REGENXBIO Inc.(RGNX) | 4,693,389 | 4,368,804 | -324,585 | $45.29M | $62.91M | 4.63% | +$17.62M |
| ADC Therapeutics SASHS(ADCT) | 15,666,731 | 15,666,731 | 0 | $62.67M | $55.30M | 4.07% | -$7.36M |
| Cogent Biosciences, Inc.(COGT) | 2,209,118 | 1,437,918 | -771,200 | $31.72M | $51.07M | 3.76% | +$19.35M |
| Annexon, Inc.(ANNX) | 6,300,644 | 10,050,644 | +3,750,000 | $19.22M | $50.45M | 3.72% | +$31.24M |
| Beam Therapeutics Inc.(BEAM) | 1,387,559 | 1,285,859 | -101,700 | $33.68M | $35.64M | 2.62% | +$1.97M |
| Neurogene Inc.(NGNE) | 1,299,022 | 1,459,599 | +160,577 | $22.51M | $30.07M | 2.21% | +$7.56M |
| Rapt Therapeutics Inc | 552,594 | 885,927 | +333,333 | $14.25M | $30.01M | 2.21% | +$15.75M |
| Absci Corporation | 8,253,316 | 8,253,316 | 0 | $25.09M | $28.80M | 2.12% | +$3.71M |
| Nuvation Bio Inc.CL A(NUVB) | 3,031,009 | 3,163,256 | +132,247 | $11.21M | $28.34M | 2.09% | +$17.13M |
| IDEAYA Biosciences, Inc.(IDYA) | 742,017 | 742,017 | 0 | $20.19M | $25.65M | 1.89% | +$5.46M |
| Shattuck Labs, Inc.(STTK) | 5,539,724 | 5,539,724 | 0 | $13.24M | $20.22M | 1.49% | +$6.98M |
| Silence Therapeutics plcADS(SLN) | 2,164,777 | 2,164,777 | 0 | $11.24M | $13.16M | 0.97% | +$1.93M |
| Zymeworks Inc.(ZYME) | 3,705,750 | 491,654 | -3,214,096 | $63.29M | $12.95M | 0.95% | -$50.35M |
| Fate Therapeutics, Inc.(FATE) | 12,872,946 | 12,872,946 | 0 | $16.22M | $12.65M | 0.93% | -$3.57M |
| Replimune Group, Inc.(REPL) | 535,818 | 1,099,756 | +563,938 | $2.25M | $10.69M | 0.79% | +$8.44M |
| DBV Technologies S.A.ADS(DBVT) | 0 | 549,840 | +549,840 | $0 | $10.54M | 0.78% | +$10.54M |
| Solid Biosciences Inc | 1,899,342 | 1,860,542 | -38,800 | $11.72M | $10.49M | 0.77% | -$1.23M |
| CeriBell, Inc.(CBLL) | 435,239 | 435,239 | 0 | $5.00M | $9.54M | 0.70% | +$4.54M |
| Establishment Labs Holdings Inc.(ESTA) | 129,364 | 112,664 | -16,700 | $5.30M | $8.21M | 0.60% | +$2.91M |
| Atara Biotherapeutics Inc | 441,701 | 441,701 | 0 | $6.33M | $7.99M | 0.59% | +$1.66M |
| Celldex Therapeutics, Inc.(CLDX) | 327,008 | 283,308 | -43,700 | $8.46M | $7.69M | 0.57% | -$765.1K |
| LivaNova PLCSHS(LIVN) | 926,799 | 118,054 | -808,745 | $48.55M | $7.26M | 0.53% | -$41.28M |
| Invivyd, Inc.(IVVD) | 2,285,320 | 2,681,159 | +395,839 | $2.51M | $6.62M | 0.49% | +$4.11M |
| Xenon Pharmaceuticals Inc.(XENE) | 0 | 133,882 | +133,882 | $0 | $6.00M | 0.44% | +$6.00M |
| Repare Therapeutics Inc | 1,586,174 | 1,586,174 | 0 | $2.79M | $4.12M | 0.30% | +$1.33M |
| ALX Oncology Holdings Inc.(ALXO) | 3,332,983 | 3,264,718 | -68,265 | $6.10M | $3.69M | 0.27% | -$2.41M |
| ORIC Pharmaceuticals, Inc.(ORIC) | 0 | 448,110 | +448,110 | $0 | $3.67M | 0.27% | +$3.67M |
| Pliant Therapeutics, Inc.(PLRX) | 1,591,695 | 1,616,228 | +24,533 | $2.36M | $1.97M | 0.15% | -$383.9K |
| Kalaris Therapeutics, Inc.(KLRS) | 82,955 | 82,955 | 0 | $479.5K | $700.1K | 0.05% | +$220.7K |
| 89bio Inc | 1,473,136 | 0 | -1,473,136 | $21.66M | $0 | — | -$21.66M |
| Akero Therapeutics Inc | 747,818 | 0 | -747,818 | $35.51M | $0 | — | -$35.51M |
| Amicus Therapeutics Inc COM | 777,178 | 0 | -777,178 | $6.12M | $0 | — | -$6.12M |
| Boundless Bio, Inc.(BOLD) | 245,458 | 0 | -245,458 | $301.9K | $0 | — | -$301.9K |
| Keros Therapeutics, Inc.(KROS) | 552,506 | 0 | -552,506 | $8.74M | $0 | — | -$8.74M |
| Lava Therapeutics NvSHS | 2,074,372 | 0 | -2,074,372 | $3.24M | $0 | — | -$3.24M |
| Prime Medicine, Inc.(PRME) | 87,118 | 0 | -87,118 | $482.6K | $0 | — | -$482.6K |
| Ventyx Biosciences Inc | 1,073,386 | 0 | -1,073,386 | $3.34M | $0 | — | -$3.34M |
| Xeris Biopharma Holdings Inc | 451,099 | 0 | -451,099 | $3.67M | $0 | — | -$3.67M |